248 related articles for article (PubMed ID: 18196550)
1. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
Tsui KH; Hsieh WC; Lin MH; Chang PL; Juang HH
Prostate; 2008 May; 68(6):610-9. PubMed ID: 18196550
[TBL] [Abstract][Full Text] [Related]
2. Cell growth effects of triiodothyronine and expression of thyroid hormone receptor in prostate carcinoma cells.
Hsieh ML; Juang HH
J Androl; 2005; 26(3):422-8. PubMed ID: 15867011
[TBL] [Abstract][Full Text] [Related]
3. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.
Tsui KH; Feng TH; Lin CM; Chang PL; Juang HH
J Androl; 2008; 29(6):661-8. PubMed ID: 18676361
[TBL] [Abstract][Full Text] [Related]
4. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
5. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
6. Ligand (T3) dependent and independent effects of thyroid hormone receptors upon human TRH gene transcription in neuroblastoma cells.
Feng P; Li QL; Satoh T; Wilber JF
Biochem Biophys Res Commun; 1994 Apr; 200(1):171-7. PubMed ID: 8166684
[TBL] [Abstract][Full Text] [Related]
7. Direct regulation of androgen receptor-associated protein 70 by thyroid hormone and its receptors.
Tai PJ; Huang YH; Shih CH; Chen RN; Chen CD; Chen WJ; Wang CS; Lin KH
Endocrinology; 2007 Jul; 148(7):3485-95. PubMed ID: 17412801
[TBL] [Abstract][Full Text] [Related]
8. L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.
Chung LC; Tsui KH; Feng TH; Lee SL; Chang PL; Juang HH
Am J Physiol Cell Physiol; 2012 Feb; 302(4):C676-85. PubMed ID: 22116304
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor regulates Cdc6 in synchronized LNCaP cells progressing from G1 to S phase.
Bai VU; Cifuentes E; Menon M; Barrack ER; Reddy GP
J Cell Physiol; 2005 Aug; 204(2):381-7. PubMed ID: 15887248
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
[TBL] [Abstract][Full Text] [Related]
11. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
12. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.
Zhang HN; Yu CX; Zhang PJ; Chen WW; Jiang AL; Kong F; Deng JT; Zhang JY; Young CY
Acta Pharmacol Sin; 2007 Mar; 28(3):423-30. PubMed ID: 17303007
[TBL] [Abstract][Full Text] [Related]
13. Localization of a negative thyroid hormone-response region in hepatic stearoyl-CoA desaturase gene 1.
Waters KM; Miller CW; Ntambi JM
Biochem Biophys Res Commun; 1997 Apr; 233(3):838-43. PubMed ID: 9168944
[TBL] [Abstract][Full Text] [Related]
14. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
15. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells.
Tsui KH; Lin YF; Chen YH; Chang PL; Juang HH
J Androl; 2011; 32(4):383-93. PubMed ID: 21051589
[TBL] [Abstract][Full Text] [Related]
17. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
18. BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity.
Hu XD; Meng QH; Xu JY; Jiao Y; Ge CM; Jacob A; Wang P; Rosen EM; Fan S
Biochem Biophys Res Commun; 2011 Jan; 404(4):903-9. PubMed ID: 21172304
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-6 is downregulated by 17-(allylamino)-17-demethoxygeldanamycin in human prostatic carcinoma cells.
Tsui KH; Feng TH; Hsieh WC; Chang PL; Juang HH
Acta Pharmacol Sin; 2008 Nov; 29(11):1334-41. PubMed ID: 18954528
[TBL] [Abstract][Full Text] [Related]
20. Manganese antagonizes iron blocking mitochondrial aconitase expression in human prostate carcinoma cells.
Tsui KH; Chang PL; Juang HH
Asian J Androl; 2006 May; 8(3):307-15. PubMed ID: 16625280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]